Yashraj Biotechnology Limited (YBL) is a part of “YASHRAJ GROUP” having
diversified interests in finance, construction, agriculture, chemicals and
biotechnology. YBL was established in 1999 with a mission to achieve excellence
in biotechnology and utilize its power for the good of humanity. The vision of
the company is to bring the benefits of molecular diagnostics to the frontlines
of health care in India, and make diagnostics affordable and easily available to
the common man.
Salient features of the company are: -
FDA (India) licensed and ISO
9001:2000 certified
- R & D
and product development approved by the Department of Science and
Industrial Research(DSIR),
Ministry of Science and Technology, Government of India.
-
CPCSEA (Government of India) Approved Experimental Animal
Facility
- GMP Documentation
- US-FDA Grade Infectious
Disease Testing
- Cell Culture Facility as per EMEA and US-FDA
Guidelines.
Worldwide diagnostic and
biotechnology companies resource us for: - Native antigenic
proteins having consistent quality and quantity.
- Customized
formulations of native antigens in accordance with their intended use.
-
Contract manufacturing for our existing products.
-
Contract manufacturing of antigens of their interest either through joint R&D
venture or exclusive technology transfer for buy back.
Newer Business Opportunities: - Supply of cell-derived
antigens and antibodies
-
Monoclonal antibodies using hybridoma technology
- Polyclonal antibodies
-
Cell Culture Facility for expression of your Patented/Proprietary Clones
(Diagnostic and/or Therapeutic)
- Use of Experimental Animal Facility for
drug development
| 
